propafenone has been researched along with Nausea in 4 studies
Propafenone: An antiarrhythmia agent that is particularly effective in ventricular arrhythmias. It also has weak beta-blocking activity.
propafenone : An aromatic ketone that is 3-(propylamino)propane-1,2-diol in which the hydrogen of the primary hydroxy group is replaced by a 2-(3-phenylpropanoyl)phenyl group. It is a class 1C antiarrhythmic drug with local anesthetic effects, and is used as the hydrochloride salt in the management of supraventricular and ventricular arrhythmias.
Nausea: An unpleasant sensation in the stomach usually accompanied by the urge to vomit. Common causes are early pregnancy, sea and motion sickness, emotional stress, intense pain, food poisoning, and various enteroviruses.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Twenty-one patients whose severe ventricular arrhythmias were not controlled by other currently used antiarrhythmic agents or who were intolerant of those drugs were treated with a new antiarrhythmic agent, propafenone." | 7.67 | Propafenone for the treatment of severe ventricular arrhythmias. ( Bar-Shlomo, B; Boroomand-Rashti, K; Rabkin, SW; Rotem, CE, 1984) |
| "Amiodarone and cedilanid may be the proper drugs for the treatment of paroxysmal atrial fibrillation in the elderly." | 3.73 | Drug therapy of paroxysmal atrial fibrillation in the elderly over 75 years old. ( Cao, J; Chen, DY; Zhu, BP, 2006) |
| "Twenty-one patients whose severe ventricular arrhythmias were not controlled by other currently used antiarrhythmic agents or who were intolerant of those drugs were treated with a new antiarrhythmic agent, propafenone." | 3.67 | Propafenone for the treatment of severe ventricular arrhythmias. ( Bar-Shlomo, B; Boroomand-Rashti, K; Rabkin, SW; Rotem, CE, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, DY | 1 |
| Cao, J | 1 |
| Zhu, BP | 1 |
| Rabkin, SW | 1 |
| Rotem, CE | 1 |
| Boroomand-Rashti, K | 1 |
| Bar-Shlomo, B | 1 |
| Cai, WM | 1 |
| Chen, B | 1 |
| Cai, MH | 1 |
| Chen, Y | 1 |
| Zhang, YD | 1 |
| Köppel, C | 1 |
| Oberdisse, U | 1 |
| Heinemeyer, G | 1 |
1 trial available for propafenone and Nausea
| Article | Year |
|---|---|
The influence of CYP2D6 activity on the kinetics of propafenone enantiomers in Chinese subjects.
Topics: Administration, Oral; Adult; Anti-Arrhythmia Agents; Area Under Curve; China; Cytochrome P-450 CYP2D | 1999 |
3 other studies available for propafenone and Nausea
| Article | Year |
|---|---|
Drug therapy of paroxysmal atrial fibrillation in the elderly over 75 years old.
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Bradycardia; Cardi | 2006 |
Propafenone for the treatment of severe ventricular arrhythmias.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Dizziness; Female; Humans; Male; Middle A | 1984 |
Clinical course and outcome in class IC antiarrhythmic overdose.
Topics: Ajmaline; Anti-Arrhythmia Agents; Bicarbonates; Bradycardia; Drug Overdose; Flecainide; Hemoperfusio | 1990 |